Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis

NCT04002349 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Determination of the Efficacy of Different Medications for Idiopathic Rhinitis
Impact of Different Medications on Biomarkers of Idiopathic Rhinitis
Safety and Tolerance of Different Medications for Idiopathic Rhinitis

Interventions

DRUG: Budesonide Nasal Spray (Rhinocort, Shanghai Johnson & Johnson Pharmaceuticals, Ltd.)
DRUG: Levocabastine Nasal Spray (Livostine, Shanghai Johnson & Johnson Pharmaceuticals, Ltd.)
DRUG: 0.9% natural saline

Sponsor

Beijing Tongren Hospital

Collaborators

[object Object]
[object Object]